pCODR Final Recommendation Issued for ibrutinib (Imbruvica) for Mantle Cell Lymphoma (MCL) NewsResearch pCODR Final Recommendation Issued for ibrutinib (Imbruvica) for Mantle Cell Lymphoma (MCL)
Health Canada Approves Venetoclax for CLL Patients With 17P deletion or if No Other Treatment Options are Available NewsResearch Health Canada Approves Venetoclax for CLL Patients With 17P deletion or if No Other Treatment Options are Available
Lymphoma Canada 2016 Research Fellowship Award NewsResearch Lymphoma Canada 2016 Research Fellowship Award
Creighton Classic – Par for the Cure – Golf Tournament News Creighton Classic – Par for the Cure – Golf Tournament
Waldenstrom’s Macroglobulinemia Patient & Caregiver Surveys News Waldenstrom’s Macroglobulinemia Patient & Caregiver Surveys
Health Canada Approves ibrutinib for Waldenström’s Macroglobulinemia NewsResearch Health Canada Approves ibrutinib for Waldenström’s Macroglobulinemia